Amgen Inc. buy marge
Start price
21.06.15
/
50%
€141.91
Target price
24.05.16
€160.00
Performance (%)
-3.29%
End price
24.05.16
€134.02
Summary
This prediction ended on 24.05.16 with a price of €134.02. With a performance of -3.29%, the BUY prediction for Amgen Inc. by marge closed slightly in the red. marge has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amgen Inc. | -2.517% | -2.517% | 6.623% | 22.719% |
| iShares Core DAX® | 0.170% | 2.184% | 15.013% | 60.946% |
| iShares Nasdaq 100 | 0.515% | 0.370% | 6.226% | 96.569% |
| iShares Nikkei 225® | 1.614% | 6.357% | 21.242% | 50.975% |
| iShares S&P 500 | -0.719% | -0.275% | 1.451% | 61.446% |
Comments by marge for this prediction
In the thread Amgen Inc. diskutieren
Amgen
Aus meinem Langfristportofolio mit den Large-cap biotechs:
1.Gilead Science (40%)
2. Amgen (15%)
3. Celgene (25%),
und den smaller-cap biotechs:
Isis Pharmaceuticals, ChemoCentryx, Acceleron,
Portola Pharmaceuticals, Cempra, Supernus mit anteiliger Gesamtgewichtung von 20%
Nachfragen zu den einzelnen Werten beantworte ich gerne.
(Laufzeit überschritten)